We found that MEG8 expression was higher in MCF10A in comparison with the three breast cancer cell lines and that this expression was lower in MDA-MB-468 and MDA-MB-231, two cell lines from basal/triple negative tumors, than in T47D, a luminal cell line (Fig. 4E). This evidence concerns the gene MEG8 and breast carcinoma.